Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India
India has granted approval to Qdenga, Takeda's vaccine, marking the nation's first regulatory clearance for a dengue immunization.
Answered
Who is eligible to receive the Qdenga vaccine in India?
The vaccine is approved for individuals between the ages of 4 and 60.
Has the vaccine been tested in India?
Yes, reports indicate that a city-based private university conducted chemical trials for the vaccine.
What is the official status of the vaccine?
The Drug Controller General of India has officially cleared Qdenga, making it the first dengue vaccine approved in the country.
Where it stands
The Drug Controller General of India (DCGI) has approved the use of Qdenga for individuals between the ages of 4 and 60. This development makes the Takeda-manufactured vaccine the first of its kind to be cleared for the country, where dengue remains a significant health concern.
Coverage from Reuters, The Hindu, NDTV, and The Indian Express emphasizes the vaccine's eligibility criteria and its role in combating rising cases of the virus across South Asia. The Times of India also reports on local clinical trials conducted at a private university, while medical perspectives provided in the coverage highlight the complexity of the four existing virus strains.
Future reports are expected to clarify rollout timelines and distribution logistics. Coverage does not yet specify when the vaccine will be available for public administration or its integration into existing national immunization programs.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46d ago.
Who reported it (8)
- Takeda's Dengue Vaccine (TAK-003) Becomes India's First Approved Dengue Vaccine, Bringing Prevention to One of the World's Most At-Risk Populations Taiwan News · 48d ago
- India approves first dengue vaccine as cases surge in South Asia The Telegraph · 48d ago
- City-based pvt varsity conducted dengue vaccine’s chemical trial The Times of India · 48d ago
- India Gets Its First Dengue Vaccine, QDENGA: Effectiveness, Doses, Eligibility Explained NDTV · 48d ago
- India approves first dengue vaccine for individuals aged 4 to 60 years The Hindu · 48d ago
- India’s first dengue vaccine approved: DCGI clears Takeda’s Qdenga for those aged 4 to 60 The Indian Express · 48d ago
- India approves dengue vaccine: Doctor explains the four virus strains and why immunity remains a major challenge The Times of India · 48d ago
- Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India Reuters · 48d ago
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Success of India’s ‘cockroach’ protests energises critics of Narendra Modi’s government
India’s Gen‑Z ‘cockroach’ protests have ended but are energising critics of Modi’s rule
The ‘cockroach’ in the machine: How Gen Z is rattling South Asia’s elites
South Asia’s political establishment faces a demographic shift as Gen Z activists redefine protest movements and influence voter blocs.
Measles Is Becoming So Common That Treatments May Soon Be Needed
U.S. measles cases have reached a 35-year high, prompting urgent vaccine pushes as outbreaks surpass previous annual totals.
Vessel sinks a week after being struck by Russian fire, Ukrainian officials say
A Ukrainian vessel sunk after a Russian strike ignites diplomatic warnings and exposes missing crew in the volatile Black Sea.
The Accidental Hero Who Faced Down India’s Government
A Boston grad’s ‘Cockroach Party’ ignited mass protests at Delhi’s Jantar Mantar, challenging India’s government and sparking global debate.
India’s Education Minister Steps Down, Handing Win to Protesters
India’s Education Minister Dharmendra Pradhan has resigned following sustained youth-led protests over exam paper leaks.